Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI).

Autor: Leuthner, Kimberly D.1 kimberly.leuthner@umcsn.com, Buechler, Kristin A.1, Kogan, David1, Saguros, Agafe1, Lee, H. Stephen2
Zdroj: Therapeutics & Clinical Risk Management. Jun2016, Vol. 12, p931-940. 10p.
Databáze: Academic Search Ultimate